IT-CHEM Co., Ltd.
IT-CHEM supplies pharmaceutical intermediates for type-2 diabetes and GERD drugs plus OLED hole-transport-layer materials as a fine chemicals company.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2005, IT-CHEM listed on KOSDAQ in 2025 as a fine chemicals materials company for pharmaceuticals and electronic materials. It supplies pharmaceutical intermediates BCBB (for type-2 diabetes drugs, production since Nov. 2020) and FOMN (for GERD drugs, since Jan. 2022), and APIs EZM (for hyperlipidemia drugs, since May 2017), OP (for antiviral drugs, since Sep. 2019), and C-SOS (for reflux esophagitis drugs, since Jan. 2017), as well as the OLED hole-transport-layer material BBNF (since Jul. 2023). Its subsidiary ST Materials produces electronic-material samples and raw materials such as L-008 (since Sep. 2023), while subsidiary KE Engineering manufactures the SR solvent recovery system, an environmental facility that recovers NMP gas at battery plants (since Jan. 2003).
Products & technology
- BCBBIntermediate for type-2 diabetes drugs
- FOMNIntermediate for GERD drugs
- EZMAPI for hyperlipidemia drugs
- OPAPI for antiviral drugs
- C-SOSAPI for reflux esophagitis drugs
- BBNFOLED hole transport layer material (Green Prime)
- L-008 and others (ST Materials)Paid samples and raw materials for electronic materials
- SR (Solvent Recovery System PKG, KE Engineering)Environmental facility recovering NMP gas at battery plants
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition